NCT07642063

Brief Summary

Aim of the work is to compare the surgical efficacy and perioperative outcomes of the inverted-T incision with early apical release technique versus the standard three-lobe technique in patients undergoing Holmium Laser Enucleation of The prostate for Benign prostatic hyperplasia . Primary outcome :

  • Technical operative time (started from the activation of the holmium laser for enucleation of the prostate lobes and ending after completion of morcellation ) Secondary outcome:
  • Laser energy used.
  • Intraoperative blood loss (change in hemoglobin level).
  • Learning curve.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Mar 2026Dec 2026

First Submitted

Initial submission to the registry

March 11, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

March 20, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

June 11, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

March 11, 2026

Last Update Submit

June 7, 2026

Conditions

Keywords

Benign prostatic hyperplasiaThree-Lobe Technique in Holmium Laser Enucleation of The ProstateInverted-T Incision with Early Apical Release Technique

Outcome Measures

Primary Outcomes (1)

  • Technical operative time

    120 minutes

Secondary Outcomes (1)

  • Intraoperative blood loss

    Intraoperative for 2 hours

Study Arms (2)

Group A: will undergo the inverted-T with early apical release technique.

EXPERIMENTAL

Patients undergo the inverted-T with early apical release technique

Procedure: inverted-T with early apical release technique

Group B: will undergo the standard three-lobe technique

EXPERIMENTAL

Patients undergo the standard three-lobe technique

Procedure: standard three-lobe technique

Interventions

Patients will undergo the inverted-T with early apical release technique. After a full-thickness incision is made at the 12 o'clock position, lateral horizontal incisions are made from the midline towards the sides, expanding the vertical incision to form the "T" shape. Then, early apical release is performed followed by dissection in the posterior plane. After that, the planes are conjoint with continued enucleation until the adenoma is totally separated.

Group A: will undergo the inverted-T with early apical release technique.

Patients will undergo the standard three-lobe technique. After enucleation, adenoma will be morcellated in the bladder using a morcellator device. 3 way urethral catheter will be inserted at the end of the procedure. Laser settings, operative time and blood loss will be recorded for every case.

Group B: will undergo the standard three-lobe technique

Eligibility Criteria

Age50 Years - 80 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale patients
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients aged 50-80 years.
  • Prostate size ≥ 80 mL.
  • Candidates for Holmium Laser Enucleation of the Prostate based on clinical and radiological evaluation

You may not qualify if:

  • Suspected or confirmed prostate cancer.
  • Previous prostate or urethral procedure (excluding prostate biopsy).
  • Urethral stricture.
  • Active urinary tract infection.
  • Urinary bladder mass, stone or diverticulum.
  • Severe coagulopathy or inability to discontinue anticoagulant/antiplatelet medications.
  • Unwillingness to comply with follow-up protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Egypt

Location

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urology Specialist, Ministry of Health

Study Record Dates

First Submitted

March 11, 2026

First Posted

June 11, 2026

Study Start

March 20, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

June 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

It will be available if it required

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations